Ophthalmic drug development: procedural considerations.
Novack
G D
GD
PharmaLogic Development, Inc., San Rafael, CA 94903, USA.
D000818:Animals; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015195:Drug Design; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D016903:Drug Monitoring; D015507:Drugs, Investigational; D006801:Humans; D017387:Investigational New Drug Application; D009883:Ophthalmic Solutions; D009885:Ophthalmology
D015507:Drugs, Investigational; D009883:Ophthalmic Solutions